- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00663585
Intensive Meditation and Migraines: Effects on Health and Well Being
July 28, 2016 updated by: Madhav Goyal, Johns Hopkins University
Participants completing training in intensive meditation and continuing frequent practice for one year would experience reduced frequency, duration and severity of headaches along with improved awareness of the triggers of their symptoms, improved quality of life and mental health, improved heart rate variability, and reduced inflammation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic Daily Headache, defined as a headache at least 15 days of the month, of which at least 8 are migraines.
Exclusion Criteria:1.
- Severe depression, anxiety, panic attacks, psychosis or dementia that may interfere with ability to participate in a 10 day course
- Active alcoholism on screening or use of illicit drugs within the last 3 months
- Already completed a 10 day course
- Actively involved in another form of meditation over the past 6 months
- Women who are pregnant, planning pregnancy during trial period, or lactating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Structured Intervention Group
|
12 day retreat where participants learn to meditate
|
|
Active Comparator: 2.Comparison group
Unstructured comparison group
|
12 day retreat where participants learn to meditate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
number of migraine days, number of headache days
Time Frame: 3,6,12 months
|
3,6,12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
severity of headaches
Time Frame: 3,6,12 months
|
3,6,12 months
|
|
quality of life
Time Frame: 3,6,12 months
|
3,6,12 months
|
|
Heart Rate Variability
Time Frame: 3,6,12 months
|
3,6,12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Madhav Goyal, MD, MPH, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2008
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
April 21, 2008
First Submitted That Met QC Criteria
April 21, 2008
First Posted (Estimate)
April 22, 2008
Study Record Updates
Last Update Posted (Estimate)
July 29, 2016
Last Update Submitted That Met QC Criteria
July 28, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NA_00016428
- RR023266
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.